Lonza Biologics plc
Research & Technology, Lonza Pharma & Biotech
The Portway, Granta Park
Cambridge CB21 6GS, UK 00000
Email: jesus.zurdo@lonza.com

Papers:
S31 Developability and pre-process risk assessment in biopharmaceutical development: a critical aspect in QbD implementation